Abstract:We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Database (CBM), VIP database, and Wanfang Data from their inception to September 18, 2022. The risk of bias of the included RCTs was assessed by the Cochrane Collaboration tool. RevMan 5.3 software and Stata 14.0 software were used to perform the statistical analysis. The GRADE system assessed the quality of evidence. Ten studies were enrolled finally. The results of the meta-analysis showed that compared with topical minoxidil alone, the 308-nm excimer laser/light or He-Ne laser combined with topical minoxidil could reduce the SALT (Severity of Alopecia Tool) score (MD= −5.88, 95% CI [−9.79, −1.98], P =0.003). Whether fractional CO 2 laser (RR=1.29, 95% CI [1.14, 1.46], P <0.0001), 308-nm excimer laser/light (RR=1.32, 95% CI [1.12, 1.55], P =0.001), He-Ne laser (RR=1.69, 95% CI [1.07, 2.69], P =0.03), or NB-UVB (RR=1.35, 95% CI [1.07,1.70], P =0.01) combined with topical minoxidil may improve the treatment response rate, comparing with topical minoxidil only. The recurrence rate of laser and light combined with topical minoxidil was lower than that of the minoxidil alone group (RR=0.54, 95% CI [0.31, 0.93], P =0.03) when follow-up time was 1 year. In addition, the incidence of adverse events including irritant contact dermatitis, erythema, desquamation, pain, and pruritus was no significant difference between the two groups (RR=1.50, 95% CI [0.95, 2.36], P =0.08). The level of evidence for outcomes was classified as very low to moderate. Based on the available evidence, laser and light combined with topical minoxidil therapy may be effective and safe for alopecia areata. However, more high-quality trials are required for comprehensive analysis and further verification.

Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata

JAK Inhibitors for the Treatment of Alopecia Areata

A review of monochromatic light devices for the treatment of alopecia areata

Pathogenesis of Alopecia Areata in C3H/He J Mice and DEBR Rats

Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle

The role of laser and energy-assisted drug delivery in the treatment of alopecia

Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil

Single-cell transcriptome analysis of fractional CO2 laser efficiency in treating a mouse model of alopecia

Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials

Lasers Uses in the Treatment of Alopecia Areata: Review Article

Hair regrowth through wound healing process after ablative fractional laser treatment in a murine model

Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model

Dermal lymphatic dilation in a mouse model of alopecia areata

Impaired autophagy promotes hair loss in the C3H/HeJ mouse model of alopecia areata

Myeloid Adherent Cells Are Involved in Hair Loss in the Alopecia Areata Mouse Model

Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes

Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies

Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma

Clinical efficacy of adipocyte-derived stem cells conditioned media combined with micro-injury in refractory patch of alopecia areata

Visual and Molecular Evidence from a Mouse Model

Low-level laser treatment stimulates hair growth via upregulating Wnt10b and β-catenin expression in C3H/HeJ mice